Home Recalls D-0167-2024
Class II · Moderate risk Terminated Initiated Jan 26, 2022 (5 years ago)
Aripiprazole Tablets, USP, 5 mg, 30 Tablets per bottle, Distributed by: Amneal…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What was recalled
Aripiprazole Tablets, USP, 5 mg, 30 Tablets per bottle, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 65162-897-03
Recalling firm Cardinal Healthcare
Origin OH, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0167-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing May 27, 2026
Reason Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Class II · Moderate risk Ongoing Aug 28, 2025
Reason Superpotent drug
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products